Brief: Carlyle Group May Sell Up To 10% Stake In India's Piramal Pharma Via Block Deals, Moneycontrol reports
03/07/2025 13:33
July 3 (Reuters) - Carlyle Group Inc CG.O: CARLYLE GROUP MAY SELL UP TO 10% STAKE IN INDIA'S PIRAMAL PHARMA VIA BLOCK DEALS - MONEYCONTROL Source text: [ID:] Further company coverage: CG.O ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma (Mumbai) Says Commercial Arrangement With Bayer Pharmaceuticals To Expire On December 31, 2026
Brief: Piramal Pharma (Mumbai) Says Tax Authority Confirms Demand Of 40.6 Million Rupees And Imposes Equivalent Penalty
India's Piramal Pharma falls after US FDA observations at UK facility
Brief: Piramal Pharma Says US FDA Issues Form-483 With 7 Observations To Morpeth UK Facility
Brief: Piramal Pharma Approves Exercise Of Call Option For Acquisition Of Additional 41% Equity In Yapan Bio